Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Celltrion USA

June 2026

Celltrion USA Market Share Analysis for June 2026

Celltrion USA Announces U.S. FDA Approval of Yuflyma® (adalimumab-aaty), a High-…,
Industry: N/A
Year Founded--
Employees51 - 200
Annual Revenue--
celltrionusa.com
Celltrion USA
Celltrion USA (including company regionals)
  • celltrionusa.com
    celltrionusa.com
See more website traffic and engagement information

Total visits to Celltrion USA's top domains

Understand Celltrion USA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Celltrion USA's top domains

Analyze Celltrion USA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
celltrionusa.comcelltrionusa.com00:01:43
See more with Sales Intelligence

Avg. pageviews on Celltrion USA's top domains

See how Celltrion USA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Celltrion USA top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Celltrion USA

These are the website technologies, by industry, used by Celltrion USA top domains

Mobile (2)

Meta Viewport

Meta Viewport

Social (2)

Instagram

Instagram

Email Services (1)

Microsoft Exchange Online

Microsoft Exchange Online

Other (1)

Google API

Google API

More Technologies

1

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Celltrion USA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCelltrion USA, Inc. launched intravenous AVTOZMA on Oct 1st '25.Celltrion had previously launched its intravenous AVTOZMA(R) in October 2025.
NewsCelltrion USA, Inc. invests into assets: biopharmaceutical manufacturing facility in the amount of $330M in New Jersey, United States, Northern America, Americas.Strategic Acquisition: Celltrion USA finalizes USD 330 Million purchase of FDA-approved biopharmaceutical manufacturing facility from Eli Lilly in New Jersey

See all Celltrion USA signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.